Suit Alleges Teva's Pergolide Damaged Heart Valves

Law360, New York (July 24, 2008, 12:00 AM EDT) -- Teva Pharmaceuticals USA Inc. has been hit with a suit claiming that pergolide, its now-withdrawn generic treatment for restless leg syndrome, causes heart valve damage, making Teva the third company to face a suit over restless leg drugs.

The latest suit was filed Wednesday in the U.S. District Court for the District of Minnesota on behalf of Leigh Ann Karnell, who took pergolide for four years and alleges that it caused her valvular heart disease. Karnell took pergolide from 2003 until it was withdrawn from the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.